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Abstract: Functional characteristics of satellite cells (SCs) that act as myogenesis initiators and have emerged as a promis-
ing target for cell therapy, are dependent on their microenvironment. The aim of this study was to investigate the effect of 
cell-free hemoglobin, as a part of the microenvironment of SCs, on their functional characteristics. The C2C12 cell line 
served as the experimental model of SCs; hemoglobin isolated from porcine (PHb) and bovine (BHb) slaughterhouse 
blood served as the experimental model for extracellular hemoglobin. The proliferation rate of C2C12 cells was assessed 
by the MTT test, migration capacity by the scratch assay, and myogenic differentiation capacity by histochemical staining 
and RT-PCR analysis of the expression of genes specific for myogenic lineage. The effect of hemoglobin on the prolifera-
tion and migration of C2C12 cells was dependent on its concentration and the animal species it was isolated from, but the 
effect of BHb was more prominent. Both PHb and BHb decreased the expression levels of myogenin and muscle specific 
creatine kinase at a 10 µM concentration. While PHb had no effect on the morphometric parameters of C2C12 myotubes, 
BHb modified the area and length of C2C12 myotubes cultivated in DMEM/2% horse serum and DMEM/10% fetal calf 
serum. While PHb and BHb had no effect on heme oxygenase 1 (Hmox1) expression, they stimulated the expression of 
hypoxia-inducible factor 1-alpha (Hif1α) at a concentration of 10 µM. The mainly inhibitory effect of cell-free hemoglobin 
on myogenic differentiation suggests that it could be a relevant factor in the outcome of cell therapy of muscle injury.
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INTRODUCTION
Muscle injuries, often seen in athletes and military 
personnel, as well as in patients undergoing surgical 
interventions (e.g. tumor ablation, soft tissue recon-
struction, joint arthroplasty) remain an unmet clini-
cal challenge, despite their relatively high incidence 
rate [1,2]. Aside from the standard RICE (rest, ice, 
compression and elevation) principle, the treatment 
for injured skeletal muscle may include medication 
(nonsteroidal antiinflammatory drugs (NSAIDs) or 
glucocorticoids), exercise, therapeutic ultrasound and 
hyperbaric oxygen therapy [1]. Beyond a certain injury 
severity threshold, the treatment may rely on surgical 
interventions or cell therapy that has emerged as an 
attractive alternative therapy for muscle injuries [3,4].
The endogenous response of skeletal muscles to 
injury or trauma depends on the highly orchestrated 
series of biological processes that are comparatively 
well-elucidated and comprised of several phases [2]. 
Following the rupture and necrosis of myofibers and 
surrounding blood vessels, hematoma is formed and a 
proinflammatory response is triggered. In this phase, 
neutrophils invade the site of injury, degrade muscle 
membranes and produce free radicals. The second phase 
is characterized by tissue repair and regeneration and 
relies on proinflammatory M1 and antiinflammatory 
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M2 macrophages. M1 macrophages remove debris, 
execute structural degradation and secrete cytokines 
that stimulate the proliferation and migration of satellite 
cells (SCs) [5], whereas M2 macrophages inhibit the 
deposition of excessive extracellular matrix (ECM) and 
stimulate the fusion of myoblasts into multinucleated 
myotubes. The final phase involves the maturation 
of myotubes into functional, contractile myofibers, 
remodeling of the connective tissue ECM, and estab-
lishment of neuromuscular junctions. The crucial part 
of this process relies on SCs that are a rare population 
of muscle-specific progenitor cells (2-7% of all muscle 
cells), and represent an appealing strategy for treating 
muscle disorders and injuries because of their intrinsic 
myogenic potential [3].
Recent reports have provided evidence that the 
functional characteristics of SCs are essentially de-
pendent on the properties of their microenvironment, 
i.e. niche [2,3]. Beside resident fibroblasts and fibro/
adipogenic progenitor cells, which secrete the muscle 
tissue extracellular matrix (ECM) [6], the microenvi-
ronment of SCs is comprised of different molecules 
found extracellularly upon rupture of myofibers and 
surrounding blood vessels, including hemoglobin (Hb). 
Although SCs have emerged as a promising target for 
cell therapy, due to their low number, limited ability 
to proliferate in vitro, intrinsic heterogeneity [7] and 
poor survival rate upon transplantation in vivo [3], the 
majority of in vitro studies aimed at the development 
of skeletal muscle are performed on well-characterized 
cell lines such as C2C12 [8]. Furthermore, in recent 
years xenogeneic hemoglobin is attracting attention 
not only as a substrate simulating the in vivo presence 
of extracellular hemoglobin but also as an agent for tis-
sue and organ preservation [9,10] or as a modulator of 
mesenchymal cell differentiation [11,12]. We have previ-
ously shown that extracellular hemoglobin originating 
from bovine erythrocytes can decrease the capacity of 
multipotent mesenchymal cells to differentiate towards 
chondrogenic, osteogenic and adipogenic lineages [12]. 
Having enucleated erythrocytes, bovine and porcine 
blood are interesting xenogeneic hemoglobin sources 
which show a high degree of homology to human HbA 
(84% and 85%, respectively) [13,14].
The aim of this work was to investigate the ef-
fect of cell-free xenogeneic hemoglobin molecules 
isolated from bovine and porcine erythrocytes, on 
the functional characteristics of myoblasts: their pro-
liferation, migration and differentiation. To the best 
of our knowledge, this issue has not been addressed 
previously. Data obtained in this study could be of 
practical importance when treating muscle injuries 
in patients with hemoglobinemia-related diseases and 
conditions, as well as when using SCs for cell therapy, 
since the presence of extracellular hemoglobin could 
potentially influence its outcome.
MATERIALS AND METHODS
Cell culture
The mouse myoblast cell line C2C12 was purchased 
from American Type Culture Collection (ATCC, USA). 
Cells were cultured in growth medium (GM) contain-
ing Dulbecco’s modified Eagle’s medium (DMEM; 
Sigma-Aldrich, USA) supplemented with 10% fetal 
calf serum (FCS; Capricorn-Scientific, Germany), 100 
U/mL penicillin and 100 µg/mL streptomycin (Gibco, 
Thermo Fisher Scientific, USA) at 37°C in humidified 
atmosphere containing 5% CO2. (standard conditions). 
The GM was replaced every second day. Upon reach-
ing a confluence of 80%, the cells were detached using 
a 0.25% solution of trypsin/EDTA (Gibco, Thermo 
Fisher Scientific, USA).
Hemoglobin isolation and characterization
The hemoglobin used in this study was isolated from 
porcine and bovine slaughterhouse blood by the process 
our group had optimized, involving gradual hypotonic 
hemolysis, as previously described [15]. Supernatants 
containing hemoglobin were purified by tangential 
microfiltration and the protein and lipid contents were 
analyzed by sodium dodecyl sulfate-polyacrylamide-gel 
electrophoresis (SDS-PAGE) and isoelectric focusing 
[16], and by thin-layer chromatography (TLC) and gas 
chromatography [17], respectively. Since UV-Vis spectra 
and dynamic light scattering analysis showed the ab-
sorption bands characteristic for native oxyhemoglobin, 
and as there were no significant individual variations 
between hemoglobin samples isolated from different 
animals of the same species [16], pooled hemoglobin 
samples were used for the cell culture experiments.
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Lipids from hemoglobin samples were extracted 
with a chloroform-methanol mixture (2:1, v/v). The 
chloroform phase was vacuum evaporated, and the 
lipids were dissolved in chloroform [18]. TLC on 
silica gel GF plates (Merck, Darmstadt, Germany) was 
used to separate and identify lipids [19]. Petroleum 
ether-diethyl ether-acetic acid (87:12:1v/v) was used 
as the solvent system for neutral lipid separation. 
Lipid bands were visualized using I2 vapor staining, 
and the lipid profiles were analyzed by densitometry. 
Lipids were identified based on their chromatographic 
mobility, using a standard lipid mixture (C.f.a.s., Cali-
brator for automated systems; Roche Diagnostics, IN, 
USA). Individual fatty acids (FA) in phospholipids 
from hemoglobin samples were determined by gas 
chromatography by comparing their retention times 
with those of commercial polyunsaturated fatty acid 
methyl esters mixture, PUFA-2 (Supelco Inc., Belle-
fonte, Pennsylvania, USA) [20].
Cell proliferation assays
The C2C12 cell proliferation rate was analyzed by the 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT; Sigma-Aldrich, St. Louis, MO, USA) 
test. Cells were seeded at a concentration of 8×103 cells/
well in GM and allowed to adhere to plastic overnight. 
The next day, hemoglobin was added to the cell culture 
at concentrations of 0.1 µM, 1 µM and 10 µM, and the 
cells were cultured for additional 24 h, 48 h and 72 
h. At the end of the incubation, MTT was added to 
the cell culture at a concentration of 0.5 mg/mL. The 
MTT incubation lasted 2.5 h during which formazan 
crystals were formed and then dissolved in 10% SDS 
with 0.01 N HCl. Absorbance at 540 nm was measured 
the next day using an automatic reader for microtiter 
plates (Labsystems Multiskan PLUS, Finland) [21].
Wound healing assay
Cell migration capacity was analyzed by in vitro wound 
healing, scratch assay. Briefly, C2C12 cells were plated 
in 24-well plates (5×104 cells/well) and cultured in GM 
until reaching confluence, when a scratch was made 
in the cell monolayer using a 200-µL pipette tip. After 
making a scratch in each plate well, the cells were 
washed two times with PBS and incubated in DMEM 
with 1% FCS and hemoglobin at concentrations of 
0.1 µM, 1 µM and 10 µM for additional 24 h and 48 
h. After the incubation period, the cells were fixed in 
ice-cold methanol for 10 min and stained with 0.1% 
crystal violet for 10 min. To visualize cell migration 
into the scratched areas, an inverted light microscope 
(Olympus BX51, Japan) was used. The scratched areas 
were photographed and quantified by TScratch software 
(Computational Science and Engineering Laboratory, 
Swiss Federal Institute of Technology, ETH Zurich, 
Zurich, Switzerland) as previously described [22].
Myogenic differentiation and semi-quantitative 
RT-PCR assay
To induce myogenic differentiation of C2C12 cells 
for the RT-PCR assay, the cells were cultured in GM, 
DMEM supplemented with 5% FCS (DMEM/5% FCS), 
and myogenic differentiation medium (MM) consisting 
of DMEM supplemented with 2% horse serum (HS) 
[22]. Upon reaching 70% confluence, hemoglobin was 
added in MM at concentrations of 0.1 µM, 1 µM and 
10 µM, and the cells were cultured for additional 6 
days. After the treatment, total cell RNA was isolated 
using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA), 
and complementary DNA (cDNA) was synthesized 
using the RevertAidTM H Minus First Strand cDNA 
Synthesis Kit (Thermo Scientific, Waltham, MA, USA), 
with oligo (dT) as a primer. Primers were designed 
using mRNA sequences of specific genes from the 
nucleotide database through the National Center for 
Biotechnology Information (NCBI) online tools and 
synthesized by Invitrogen (Carlsbad, CA, USA). The 
primer sets, corresponding annealing temperatures 
and the number of amplification cycles are provided in 
Supplementary Table S1. As a control for the amount 
of cDNA in each sample, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) expression was assessed. 
PCR products were resolved in 1.5% agarose gel and 
stained with ethidium bromide. The intensities of 
the gel bands in the agarose gel were quantified us-
ing TotalLab TL120 (TotalLab Ltd, Newcastle Upon 
Tyne, UK). The expression levels of the analyzed genes 
were normalized to GAPDH and set as 100% for the 
control culture. The relative expression of the genes 
in the presence of hemoglobin was calculated as the 
percentage of the change compared to the control.
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Myogenic differentiation and morphometric 
analysis
Myogenic differentiation of C2C12 cells for morpho-
metric analysis was induced by prolonged cultivation 
(40 days) of cells in DMEM/5% FCS. After this period, 
the cells were seeded in a concentration of 8×103 cells/
well in DMEM/5% FCS and upon reaching 70% conflu-
ence, they were cultured for an additional 6 days with 
hemoglobin added to: DMEM/5% FCS, DMEM/2% 
HS, or DMEM/10% FCS. After these different treat-
ments, the cells were fixed and stained according to the 
protocol described in the wound healing assay section. 
Morphometric parameters of the formed myotubes 
were determined using a light microscope and a digital 
camera system (Olympus BX51, Japan) as previously 
described [23]. Namely, C2C12 cells were cultured in 
different media in 6-well plates; 10 myotubes per well 
were photographed and measured, or all the observed 
myotubes for the given treatment if their number was 
<10. The area, length, average width and hypertrophy 
index of each myotube were determined using NIH-
ImageJ software (National Institute of Health, USA). 
The average width was calculated by taking 3 short-axis 
measurements along the length of a given myotube 
and calculating the average value.
Statistical analysis
Statistical analysis was performed using Student’s t-test 
by Microsoft Office Excel 2010 software (Microsoft 
Corporation, Wash., USA). Differences were consid-
ered significant at a value of *P<0.05.
RESULTS
The effect of hemoglobin on C2C12 cell 
proliferation rate 
To assess the effects of PHb and BHb on the prolifera-
tion rate of  C2C12, we examined 3-day cultures using 
the MTT assay. The spontaneous cell proliferation rate 
(cells grown in GM only) increased over time (Fig. 1A). 
PHb significantly reduced the viability of C2C12 cells 
at concentrations of 1 μM and 10 μM after 24 h, 48 h 
and 72 h, while having no effect at the concentration of 
0.1 μM (Fig. 1B). BHb reduced the viability of C2C12 
cells after 24 h at all 3 examined concentrations. Af-
ter 48 h this inhibitory effect was manifested only at 
concentrations of 1 μM and 10 μM. In contrast, BHb 
increased the viability of C2C12 cells at all 3 tested 
concentrations after 72 h in culture (Fig. 1C).
Fig. 1. The effect of porcine (PHb) 
and bovine (BHb) hemoglobin 
on C2C12 cell proliferation rates: 
Spontaneous proliferation of C2C12 
cells after 24 h, 48 h and 72 h in 
culture, assessed by the MTT assay 
(A). The results are expressed as 
percentages of the cell proliferation 
rate after 24 h in culture (100%). 
The effect of 0.1 µM, 1 µM  and 
10 µM PHb (B) and BHb (C) on 
the proliferation rate of C2C12 
cells. The results are expressed as 
relative to corresponding control 
level (GM=100) and mean±SD (n 
= 3); * P<0.05, PHb/GM vs GM or 
BHb/GM vs GM.
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The effect of hemoglobin on C2C12 cell 
migratory capacity
The effect of medium supplementation with porcine 
and bovine hemoglobin on the migratory capacity of 
C2C12 cells was analyzed by the scratch assay. After 
making a scratch in C2C12 cell monolayers, PHb and 
BHb were added at concentrations of 0.1 µM, 1 µM and 
10 µM. Cells were allowed to migrate for 24 h and 48 
h since after 24 h no changes in scratch closure were 
observed for cells cultured with PHb (Fig. 2A). In 
contrast to this, BHb stimulated the migratory capacity 
of the cells after 24 h at all tested concentrations (Fig. 
2B), and only at the concentration of 10 µM after 48 
h (Fig. 2D). The same positive effect on the migratory 
capacity of C2C12 cells was observed at all examined 
PHb concentrations in the 48-h cultures (Fig. 2C).
The effect of hemoglobin on C2C12 myogenic 
differentiation capacity 
To further investigate the effect of PHb and BHb on the 
functional activity of C2C12 cells, we analyzed their 
influence on the ability of C2C12 cells to differentiate 
towards the myogenic lineage. Gene expression analysis 
of C2C12 cells after 6 days of myogenic differentiation 
Fig. 2. The effect of porcine (PHb) and 
bovine (BHb) hemoglobin on the migra-
tory capacity of C2C12 cells assessed 
by the scratch assay. Upon making a 
scratch in the cell monolayer of each 
well the cells were seeded on, the cells 
were cultured in the presence of 0.1 
µM, 1 µM  and 10 µM PHb or BHb for 
24 h (A) and 48 h (B) and stained with 
crystal violet. Cells in wells labeled GM 
t0 were fixed immediately after making 
the scratch. The numbers represent 
percentages of the scratch areas covered 
with migrating cells relative to GM t0 
(100%). Representative micrographs 
are shown; magnification ×40. The 
results are expressed as the mean±SD 
(n=3); *P<0.05, PHb/GM vs GM or 
BHb/GM vs GM.
Fig. 3. The effect of porcine (PHb) (A) 
and bovine (BHb) (B) hemoglobin on 
the expression of specific myogenic 
markers, and HIF-1 and HO in C2C12 
cells after 6 days of cultivation in myo-
genic medium (DMEM/2% HS, MM). 
Using RT-PCR, the expression of Myog, 
Ckm, Hif1a and Hmox1 genes in C2C12 
cells was assessed. GAPDH was used 
as a gel loading control. Representative 
RT-PCR bands are shown as well as 
quantitative data of RT-PCR results. The 
expression level of each gene in MM 
was normalized to the corresponding 
expression level of GAPDH (marked 
with an #) and presented as 100%. The 
results are shown as the mean±SEM 
(n=3) *P<0.05, PHb/MM vs MM or 
BHb/MM vs MM.
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induction showed that in the myogenic differentiation 
medium (MM = DMEM/2% HS) C2C12 expressed 
both myogenin (MYOG, encoded by the Myog gene) 
and creatine kinase specific for muscle tissue (CKM, 
encoded by the Ckm gene). Both PHb and BHb at 
concentrations of 0.1 µM and 1 µM did not influ-
ence the expression levels of Myog in C2C12 cells, 
but slightly decreased it at a concentration of 10 µM 
(Fig. 3A, B). At concentrations of 0.1 µM and 1 µM, 
BHb increased the expression of Ckm, while PHb had 
no effect on the expression of this myogenic marker 
at these concentrations. In contrast, both PHb and 
BHb significantly decreased the expression of Ckm 
at a concentration of 10 µM (Fig. 3A, B). While the 
expression of heme oxygenase-1 (HO-1) mRNA was 
not detected by RT-PCR, the influence of PHb and BHb 
on the expression pattern of hypoxia-inducible factor 
1 subunit α (HIF-1α) mRNA was dose-dependent and 
more pronounced in cells cultured with BHb. While 
PHb had no effect on Hif1a expression at concentra-
tions of 0.1 μM and 1 µM, it stimulated its expression 
at a concentration of 10 µM. The effect of BHb on 
Hif1a expression was stimulatory at every tested con-
centration. Our results also showed that C2C12 cells 
express Myog and Ckm at a low basal level even in 
GM (DMEM/10% FCS) and in a medium containing 
two-fold less serum (DMEM/5% FCS) than the GM. 
As a result, we decided to test the effect of PHb and 
BHb supplementation of these 3 different media on 
the morphometric parameters of C2C12 myotubes 
after their cultivation in DMEM/5% FCS.
Fig. 4. Representative micrographs 
of C2C12 myotubes formed after 
prolonged cultivation (40 days) 
in DMEM/5% FCS prior to 6 
days cultivation in DMEM/5% 
FCS (A), DMEM/2% HS (B) and 
DMEM/10% FCS (C) supple-
mented with 0.1 µM, 1 µM  and 
10 µM porcine (PHb) or bovine 
(BHb) hemoglobin. Myotubes were 
analyzed and photographed using 
a light microscope and a digital 
camera system (Olympus BX51, 
Japan), magnification ×40.
The effect of hemoglobin on the morphometric 
parameters of C2C12 myotubes
Myotube formation was observed in cells cultured 
in MM and DMEM/5% FCS after 6 days, but not in 
GM (Supplementary Fig. S1). Since the expression 
patterns of myogenic markers in C2C12 cells showed 
that DMEM/5% FCS can also act as a medium for 
the induction of myogenic differentiation of these 
cells, we decided to analyze the effects of prolonged 
cultivation (40 days) of C2C12 cells in this medium, 
and to see whether adding PHb/BHb to this medium, 
or whether switching back to the conventionally used 
MM (DMEM/2% HS) or GM (DMEM/10% FCS) 
media with or without PHb or BHb, would affect the 
formation and morphology of C2C12 myotubes.
After growth in DMEM/5% FCS, C2C12 cells 
formed large hypertrophied myotubes (Fig. 4A) and 
the addition of PHb or BHb did not influence the 
morphometric parameters (area, length, average width 
and the hypertrophy index (H.I.)) of the analyzed 
myotubes (Fig. 5A, D). When switching back to the 
routinely used MM for the induction of myogenic 
differentiation of C2C12 cells, DMEM/2% HS, the 
myotubes were significantly smaller (Fig. 4B). PHb at 
concentrations of 0.1 µM and 1 µM had no influence 
on the morphometric parameters of C2C12 myotubes 
in this experimental setup (Fig. 5B), while the addi-
tion of BHb to DMEM/2% HS increased the area of 
the formed myotubes at the concentration of 0.1 µM, 
and decreased the length at the concentration of 1 µM 
(Fig. 5E). In the medium supplemented with 10 µM 
PHb or BHb, no myotubes were formed (Fig. 5B, E).
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When cultured in GM for an additional 6 days, 
the myotubes assumed their usual long and narrow 
morphology (Fig. 4C). Myotubes were detected in 
the medium supplemented with either 0.1 µM PHb 
or 0.1 µM and 1 µM BHb. PHb had no effect on the 
morphometric parameters of these myotubes (Fig. 
5C), while BHb decreased the area of myotubes at 
concentrations of 0.1 µM and 1 µM (Fig. 5F). No 
myotubes were detected in GM supplemented with 1 
µM and 10 µM PHb or with 10 µM BHb (Fig. 5C, F).
Lipid content in hemoglobin samples
Using TLC, both porcine and bovine hemoglobin 
samples were analyzed for the presence of inevitable 
impurities originating from erythrocyte membranes 
during the isolation process. Phospholipids were the 
only lipids identified in hemoglobin samples of both spe-
cies (Fig. 6A). Ten FA were identified in phospholipids 
originating from PHb, and 6 in phospholipids present 
in the BHb (Fig. 6B). Saturated FA (palmitic and stearic 
acid) were the most dominant FA in the hemoglobin 
samples of both species (>50%), but monounsaturated 
(MUFA) and polyunsaturated FA (PUFA) were also 
detected. The amount of palmitic acid was higher in 
PHb samples compared to BHb samples, while the 
percentage of stearic acid was approximately equal in 
the hemoglobin samples of both species. The MUFAs 
detected in PHb samples were palmitoleic, oleic and 
vaccenic, while oleic acid was the only MUFA detected 
in the BHb sample. Five PUFA were detected in PHb 
samples (linolenic, γ-linolenic, α-linolenic, dihomo-
Fig. 5. Morphometric analysis of C2C12 
myotube parameters after prolonged 
cultivation (40 days) in DMEM/5% 
FCS followed by 6 days cultivation in 
DMEM/5% FCS (A and D, respectively), 
DMEM/2% HS (B, E), and DMEM/10% 
FCS (C, F), supplemented with 0.1 µM, 
1 µM  and 10 µM porcine (PHb) (A, B 
and C, respectively) and bovine hemo-
globin (BHb) (D, E and F, respectively). 
The area, length, average width and 
hypertrophy index (HI) are shown. The 
results are expressed as relative to the 
corresponding control level (medium 
without hemoglobin = 100%) and the 
mean±SD (15<n<60); *P<0.05, PHb/
GM vs GM or BHb/GM vs GM.
Fig. 6. TLC analysis of the lipid content in PHb and BHb isolates. 
The dashed arrow points to the non-specific butyl-hydroxy-toluene 
band (A). The fatty acid (FA) content in phospholipids in PHb and 
BHb isolates determined by gas chromatography (B). The results 
are expressed as the mean±SD (n=3).
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γ-linolenic, arachidonic and linoleic acid), and three 
(dihomo-γ-linolenic, arachidonic, and linoleic acid) 
in the BHb sample.
DISCUSSION
While sequestered within the confines of the erythro-
cytes, hemoglobin has a role in the transport of gaseous 
molecules, maintaining cellular bioenergetic homeostasis 
and signaling, and modulating inflammatory responses 
[24]. When present in the extracellular environment, 
hemoglobin can acquire numerous functions that ex-
ceed its roles while sequestered inside of erythrocytes. 
Extracellular hemoglobin is a potentially dangerous 
redox-sensitive molecule with a high potential for 
producing reactive oxygen species (ROS) that pose a 
threat to cellular integrity [25]. Additionally, hemoglobin 
and its degradation products are defined as alarmins 
or indicators of different pathological states and condi-
tions in organism. Also, hemoglobin can interact with 
microbial ligands, such as lipopolysaccharide (LPS) and 
lipoteichoic acid (LTA), and immune system receptors, 
such as Toll-like receptors (TLRs), modulating the 
host immune response to pathogens [26]. Numerous 
studies have confirmed the role of hemoglobin in the 
pathophysiology of various diseases, such as paroxysmal 
nocturnal hemoglobinuria (PNH), sickle cell disease 
(SCD), Alzheimer’s disease, multiple sclerosis, cerebral 
intraventricular hemorrhage and preeclampsia [24,27-30].
Muscle tissue growth and regeneration relies on 
SCs, a well-known muscle-resident cell population, 
located between muscle fiber and the basal lamina 
[2,31]. SCs are naturally quiescent until an activation 
signal arrives from injured myofibers, when these cells 
migrate from their niche and interact with the compo-
nents of their environment to promote muscle tissue 
regeneration through myogenic differentiation [3,32]. 
Damaged muscle cells express and secrete numerous 
factors, amongst which is stromal cell-derived factor-1 
(SDF-1), also known as chemokine CXCL12, the ligand 
for CXCR4, which facilitates the migration of SCs to 
the site of injury [31], enhancing their proliferation 
and subsequent differentiation into myoblasts. During 
the proliferation phase, activated SCs secrete factors 
to promote the survival and differentiation of other 
cells. By then, SCs have migrated to the site of injury, 
proliferated and initiated the myogenic differentiation 
process. Macrophages that will support muscle tissue 
regeneration usually reach the muscle on about the 
second day after injury [2]. These macrophages are also 
involved in the clearance of hemoglobin-haptoglobin 
complexes (via the CD163 receptor) [33], giving the 
extracellular hemoglobin and its degradation products 
enough time to exhibit their effects on the functional 
characteristics of the surrounding cells. It was demon-
strated that in patients with persistently elevated levels 
of cell-free hemoglobin that exceed the capacities of 
their scavenging mechanisms, skeletal muscle function 
and regeneration are impaired due to the presence of 
hemoglobin [34].
To the best of our knowledge, this is the first study 
of the effect of extracellular hemoglobin on myoblast 
cells proliferation. The effect of hemoglobin and its 
degradation products, heme, hemin and peptides, on 
the viability/proliferation of cells has been investigated 
thoroughly on numerous primary cells and cell lines. 
These results are controversial, as they indicate that this 
effect depends on cell type, hemoglobin concentration 
and the species it was isolated from, as we have also 
previously demonstrated [12].
Our results show that PHb decreased the C2C12 
proliferation rate at concentrations of 1 μM and 10 μM 
but had no effect at a concentration of 0.1 µM. These 
results are in agreement with the results of several 
other studies. Namely, HEMOXCell®, extracellular 
hemoglobin extracted from a marine invertebrate 
Nereis virens [35], decreased the viability of the CHO-
S cell line at concentrations of 1 g/L and 2 g/L [36], 
which correspond to the highest concentrations used 
in our study. Furthermore, the tetrapeptide derived 
from BHb exhibited slight cytotoxicity on the human 
pancreatic cancer MIAPaCa-2 cell line at concentra-
tions of 0.1-0.4 mg/mL after 72 h of incubation [37]. 
At concentrations of 0.25, 0.5 and 1 mg/mL, human 
hemoglobin decreased the viability of human umbilical 
vein endothelial (HUVEC) cells after 24 h, 48 h and 
72 h of incubation [38]. At high concentrations (1-5 
g/L), human hemoglobin also decreased the viability 
of human U251 glioblastoma cells in hypoxic culture 
[39]. The cytotoxic effect of hemoglobin and hemin on 
neurons and glial cells has also been reported [40-42]. 
The effect of BHb on the proliferation rate of C2C12 
cells was similar to that observed after exposure to 
PHb for 24 h in culture (i.e. a decreased proliferation 
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rate at all concentrations tested) and for 48 h (i.e. a 
decreased proliferation rate at concentrations of 1 
µM and 10 µM), but interestingly, BHb stimulated 
the proliferation of these cells after 72 h at all 3 tested 
concentrations. A few studies describe cell viability/
proliferation stimulation as one of the effects of hemo-
globin on the functional characteristics of cells. Namely, 
human hemoglobin stimulated the proliferation of 
colon cancer cell lines, HT-29 and Lovo, as well as of 
the normal colonic fibroblast cell line, CCL-33Co in 
a dose-dependent manner [43]. Bovine hemoglobin 
supplementation (15 g/L) supported the maintenance 
of a higher hepatocyte cell mass in hepatic hollow fi-
ber bioreactors [44] and dose-dependently increased 
cell viability of rat primary astrocyte cultures [45]. 
As we are aware of the limitations of the MTT assay 
in measuring cell viability [46,47], further studies are 
needed to elucidate the molecular mechanisms that 
underlie the observed effect of hemoglobin on cell 
proliferation rate and to investigate whether it is due 
to heme/hemin, globin chains or iron derived from 
the hemoglobin molecule.
To the best of our knowledge, no single study has 
addressed the issue of hemoglobin influence on myo-
blast mobilization and migration before. After 24 h in 
culture, PHb did not influence the migratory capacity 
of C2C12 cells. Thus, we decided to prolong the assay 
for an additional 24 h. After 48 h, PHb slightly inhibited 
the migration of these cells, which is in accordance 
with a previous study that showed that HbA1c, gly-
cated hemoglobin isolated from patients with type 2 
diabetes, reduced the migration of HUVEC cells in a 
dose- and time-dependent manner [48]. Also, it was 
reported that two peptides derived from BHb blocked 
about 50% and 30% wound closure in a scratch assay of 
the MIAPaCa-2 cell line when compared to the control 
group after treating for 72 h [37]. At variance with the 
effect of PHb, BHb in our study stimulated the migra-
tion of C2C12 cells after 24 h in culture, and since the 
scratch of cells in the medium without hemoglobin 
was nearly entirely closed after 48 h, this effect of BHb 
was observed only at the highest concentration used 
for 48 h in culture. The stimulatory effect of BHb on 
cell migration was previously also reported for glioma 
cells under hypoxic conditions [39].
The C2C12 cell line, a myoblast cell line derived 
from murine satellite cells, is extensively used as an in 
vitro model to study myogenesis [23,49]. Upon changing 
sub-confluent C2C12 cultures from high-serum (10% 
FCS) to low-serum conditions (2–5% HS), these cells 
exit the cell cycle, commit to myogenic differentiation 
and fuse with other myoblasts to form multinucleated 
myotubes. As the process of myogenesis advances, 
the myotubes become more elongated and start to 
express proteins such as myosin, a-actin, troponin, 
MYOG, CKM and other components of the muscle-
contractile machinery [49]. Quiescent SCs do not 
express muscle-specific transcription factors including 
MYOG [31]. Newly formed, young myoblasts do not 
express MYOG, and its absence prevents their differ-
entiation into myofibers or fusion with the old ones, 
instead allowing cell proliferation. When the number 
of myoblasts increases, the expression of MYOG in 
SCs is stimulated, leading to myoblast differentiation 
[6]. Considering this, MYOG is considered an early 
marker of myogenesis. In contrast, muscle creatine 
kinase, the enzyme with a crucial role in muscle cell 
energy management, represents a late marker of myo-
genesis [50,51]. We therefore decided to test the effect 
of hemoglobin on the expression patterns of both of 
these markers to investigate their effects on myogenesis 
at two points of time, at the beginning of this process 
and later. Our results show that both PHb and BHb 
decreased the expression levels of Myog and Ckm at 
the concentration of 10 µM. Even though previous 
reports of the effect of hemoglobin on myogenic cell 
differentiation do not exist, we showed that BHb de-
creased the capacity of mesenchymal stem cells and 
different cell lines towards chondrogenic, osteogenic 
and adipogenic differentiation [12]. At odds with our 
results, it was reported that hemin enhanced the fu-
sion and maturation of cultured regenerated skeletal 
myotubes while the ferrous ion had no effect on these 
cells [52]. Since in our study neither PHb nor BHb 
triggered the expression of Hmox1, we hypothesized 
that the hemoglobin molecule remained intact in the 
C2C12 culture and exhibited an effect that was different 
from the effect of its degradation products. Nonethe-
less, without further and more sophisticated analysis 
of the fate of the hemoglobin molecule in C2C12 cell 
culture, hemin, globin chains and iron cannot be ex-
cluded as the potential inducers of the observed effects 
on myogenic differentiation of C2C12 cells.
In the elucidation of the molecular mechanism 
underlying the observed effect of hemoglobin on myo-
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genic differentiation, in addition to Hmox1 expression, 
we also analyzed Hif1α expression. It is known that 
hypoxia through HIF-1α and Notch signaling can block 
the differentiation of myogenic progenitors [53]. Given 
that our results showed that both PHb and BHb at the 
highest concentration tested (10 μM) stimulated the 
expression of Hif1α in C2C12 cells and that this effect 
of BHb was more prominent, we concluded that this 
can potentially explain the observed downregulation 
of myogenic markers (Myog and Ckm). Furthermore, 
hypoxia through HIF-1 can promote the proliferation 
of skeletal myoblasts [54]. Therefore, we hypothesized 
that the observed stimulation of the proliferation rate 
of C2C12 cells in the presence of BHb was at least in 
part due to the upregulation of Hif1α in these cells. 
We are aware of the limitations of the MTT assay, 
which depends on the metabolic rate and number 
of mitochondria in the cells [55]. Hence, the results 
obtained in this study can be viewed in the context of 
recently published data that show that upregulation 
of aerobic metabolism can enhance the proliferative 
capacity, osteogenic potential and migration capacity 
of MSCs in vitro [56].
Several methods can be applied to quantify the 
in vitro myogenic differentiation of C2C12 cells [8]. 
Determining the expression levels of myotube-specific 
genes and proteins provides an overall and unbiased 
measure of differentiation but does not inform about 
the shape and size of myotubes or the effect of the tested 
agents on these parameters. It is for this reason that we 
decided to perform an analysis of the morphometric 
parameters of C2C12 myotubes. It is well known that 
withdrawal of serum from C2C12 cells causes them 
to exit the cell cycle and fuse into myotubes [8,23]. 
Furthermore, the extent of differentiation and the 
morphological characteristics of formed myotubes 
depend on the type of media used to culture them, the 
concentration of serum in the media and the length 
of incubation [8]. C2C12 cells also provide a well-
characterized in vitro model system for studying the 
induction of hypertrophy in myotubes that occurs as 
a result of an increase in size rather than an increase 
in the number of myotubes [23]. Accordingly, our 
results showed that prolonged cultivation of C2C12 
cells in DMEM/5% FCS led to the formation of the 
large hypertrophied myotubes and that hemoglobin did 
not significantly influence their morphometric param-
eters. This is probably to a large extent due to myotube 
hypertrophy that masked the subtle potential changes 
in their biochemical and subsequent morphometric 
parameters by hemoglobin. Subsequent cultivation of 
C2C12 cells for only six days in the DMEM/2% HS 
myogenic differentiation medium that is routinely used 
for the induction of myogenic differentiation, caused 
the cells to become smaller and mostly polygonal, 
which is in accordance with the observed morphology 
of C2C12 myotubes upon cultivation of these cells in 
DMEM/2% HS after growth in GM (DMEM/10% FCS) 
[22]. When switching to cultivation in DMEM/10% 
FCS after prolonged cultivation in DMEM/5% FCS, 
the morphology of C2C12 myotubes changes and they 
become more elongated. While PHb did not affect the 
morphometric parameters of C2C12 myotubes in any of 
the experimental frameworks and used concentrations, 
BHb exerted an effect on the area of myotubes when 
cultured in DMEM/2% HS and DMEM/10% FCS, as 
well as on the length when cultured in DMEM/2% HS, 
once again confirming the potency of BHb over PHb 
in modifying the functional characteristics of C2C12 
cells. When cultured in the presence of the highest 
concentration of hemoglobin (10 μM), no myotubes 
were observed after cultivation in DMEM/2% HS and 
DMEM/10% FCS, which is in accordance with our 
RT-PCR results that showed that this concentration 
downregulated the expression of myogenic markers.
The observed differences in the effects of PHb 
and BHb on the functional characteristics of C2C12 
cells can be the consequence of differences in the pri-
mary and higher levels of structure of these proteins 
[57,58]. Additionally, our results showed the presence 
of phospholipid FAs in hemoglobin samples whose 
distribution and amounts differ in isolates from dif-
ferent species. Literature data confirm the effect of 
the FAs on myogenic differentiation. Supplementa-
tion with linoleic acid impaired muscle regeneration 
and increased fibrous tissue deposition, resulting in 
prolonged contractile function recovery, while oleic 
acid supplementation reduced fibrous tissue depo-
sition and improved contractile function recovery 
[59]. Palmitic acid suppressed C2C12 cells myogenic 
differentiation in vitro [60,61], while other studies 
demonstrated an inconsistent effect of α-linolenic 
acid [62,63]. Additionally, it is known that the FA 
compositions of commercially available serum used 
to supplement cell culture media widely differ and 
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can alter cellular FA composition and potentially the 
functional characteristics of cells [64,65].
CONCLUSION
In this study, we showed that extracellular hemoglobin 
modifies the proliferation and migration of C2C12 cells 
in a dose- and time-dependent manner, while having 
a mainly inhibitory effect on myogenic differentiation 
of these cells. These findings could be of particular 
importance for treating muscle injuries in patients with 
hemoglobinemia-related diseases and conditions. This 
should also be kept in mind when using SCs for cell 
therapy, since the presence of extracellular hemoglobin 
can influence its outcome.
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